Mumbai, July 28 -- A clinically challenging case involving Wockhardt's novel antibiotic Zaynich(R) was recently published in the July 17, 2025 issue of the Journal of Antimicrobial Chemotherapy - AMR, a leading publication by the British Society for Antimicrobial Chemotherapy. The publication details the successful use of Zaynich(R), a combination of Zidebactam and Cefepime, in treating a critically ill U.S. liver transplant patient suffering from a pan-drug resistant infection-an infection resistant to all available antibiotics in the United States. This case report is jointly authored by US clinicians from leading hospitals, Houston Methodist Hospital, Weill Cornell Medical College and Johns Hopkins.
Published by HT Digital Content Ser...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.